ClinicalTrials.gg

Program

AURN001

A development code. Also written as “Combination Product: AURN001 + Y-27632” and “Cryopreserved AURN001”.

Its studies are mostly in Corneal Edema, led by Aurion Biotech.

Furthest: phase 3, since Jan 23, 20263 company-led studies, 2 open or runningNext primary completion: Jun 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Aurion Biotech32 open or runningphase 3since Jan 23, 2026Sep 11, 2023Jun 2027phase 3 · NCT07368959

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 11, 2023First study: phase 2 study in Corneal EdemaFirst studyNCT06041256 · 97 enrolled · United States, Canada
  2. Oct 4, 2024Phase 2 study in Corneal EdemaNCT06630169 · 25 enrolled · El Salvador
  3. Jan 23, 2026Phase 3 study in Corneal EdemaPhase 3 reachedNCT07368959 · 130 enrolled · United States

Ahead

  1. Jun 2027Primary completion: phase 3 study in Corneal EdemaNCT07368959

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07368959Corneal Edema · United States3Active, not recruitingJun 2027130
NCT06630169Corneal Edema · El Salvador2Active, not recruitingOct 202525
NCT06041256Corneal Edema · United States, Canada2CompletedOct 25, 202497

How it is read

Names in the registry

  • “Combination Product: AURN001 + Y-27632”, 1 entry
  • “AURN001”, 1 entry
  • “Cryopreserved AURN001”, 1 entry

Codes read as this program: AURN001.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.